Show simple item record

dc.creatorCampos Fernández, Cristian Saúl
dc.creatorProcúpez Schtirbu, Rolando
dc.creatorSoto Tellini, Victor Hugo
dc.creatorSalazar Camacho, Juan Carlos
dc.creatorJancik, Vojtech
dc.date.accessioned2022-10-26T19:46:57Z
dc.date.available2022-10-26T19:46:57Z
dc.date.issued2022-10-12
dc.identifier.citationhttps://iucrdata.iucr.org/x/issues/2022/10/00/bt4124/index.htmles_ES
dc.identifier.isbn2414-3146
dc.identifier.urihttps://hdl.handle.net/10669/87554
dc.description.abstractThe title compound, C 35H 57 NO 3 0.25H 2O, was synthesized from deoxycholic acid followed by a protection, a Mitsonobu substitution, a Staudinger reduction, formation of an amide and final reduction in the lateral chain. The compound crystallizes in the P1 space group with four steroid molecules and one water molecule in the triclinic cell unit. The crystal structure features O—H O hydrogen bonding. The crystal studied was refined as a non-merohedral twines_ES
dc.description.sponsorshipUniversidad de Costa Ricaes_ES
dc.language.isoenges_ES
dc.sourceIUCrData, 7(10).es_ES
dc.subjectQuímica Cristalografíaes_ES
dc.subjectbiological activityes_ES
dc.subjectcrystal structurees_ES
dc.subjectbile saltses_ES
dc.title(1S,3R)-N-{(3S,10S,12S,13R,17R)-12-Hydroxy-17- [(R)-5-hydroxypentan-2-yl]-10,13-dimethylhexa- decahydro-1H-cyclopenta[a]phenanthren-3-yl}- adamantane-1-carboxamide 0.25-hydratees_ES
dc.typeartículo originales_ES
dc.identifier.doidoi.org/10.1107/cm_01
dc.description.procedenceUCR::Vicerrectoría de Docencia::Ciencias Básicas::Facultad de Ciencias::Escuela de Químicaes_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record